This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Sándor Garaczi: Innovator in Pharmaceutical Chemistry
Introduction
Sándor Garaczi is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing important compounds.
Latest Patents
Garaczi holds a patent for a method for producing lamotrigine, a medication used to treat epilepsy and bipolar disorder. The patent, titled "Method for producing lamotrigine from α-oxo-2,3-dichlorophenyl acetamidino-aminoguanidino hydrazone by ring closure reaction," describes a cyclization reaction that transforms α-oxo-2,3-dichlorophenylacetamidino-aminoguanidino-hydrazone into 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine (lamotrigine). This innovation is crucial for enhancing the production efficiency of this important pharmaceutical compound.
Career Highlights
Throughout his career, Sándor Garaczi has demonstrated a strong commitment to advancing pharmaceutical research. His work has led to the successful development of a method that not only improves the synthesis of lamotrigine but also contributes to the broader field of medicinal chemistry.
Collaborations
Garaczi has collaborated with several professionals in his field, including Csaba Lehel Gegő and Levente Ondi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Sándor Garaczi is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact. His patent for the production of lamotrigine showcases his innovative approach to solving complex chemical synthesis challenges. His contributions continue to influence the field and improve the availability of essential medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile